Suppr超能文献

全静脉麻醉和麻醉药理学的最新进展。

Recent advancements in total intravenous anaesthesia and anaesthetic pharmacology.

作者信息

Bajwa Sukhminder Jit Singh, Vinayagam Stalin, Shinde Surekha, Dalal Shital, Vennel Jessy, Nanda Samridhi

机构信息

Department of Anaesthesiology and Intensive Care, Gian Sagar Medical College and Hospital, Banur, Patiala, Punjab, India.

Department of Anaesthesiology and Critical Care, JIPMER, Puducherry, India.

出版信息

Indian J Anaesth. 2023 Jan;67(1):56-62. doi: 10.4103/ija.ija_1022_22. Epub 2023 Jan 21.

Abstract

Target-controlled infusion pumps and depth of anaesthesia monitors have made total intravenous anaesthesia (TIVA) easy, safe, and precise. The merits of TIVA were highlighted during the coronavirus disease 2019 (COVID-19) pandemic, confirming its potential further in the post-COVID clinical practice as well. Ciprofol and remimazolam are newer drugs that are being tried with a hope to upgrade the practice of TIVA. While research on safe and effective drugs continues, TIVA is being practised with a combination of drugs and adjuncts to overcome the disadvantages of each and to provide complete and balanced anaesthesia with additional benefits in recovery and pain relief postoperatively. Modulation of TIVA for the special population groups is still under process. Advancement in digital technology with mobile apps has increased the scope of TIVA in day-to-day use. The formulation and update of guidelines can establish a safe and efficient practice of TIVA.

摘要

靶控输注泵和麻醉深度监测仪使全凭静脉麻醉(TIVA)变得轻松、安全且精确。在2019冠状病毒病(COVID-19)大流行期间,TIVA的优点得到了凸显,这也证实了其在COVID后临床实践中进一步应用的潜力。环泊酚和瑞马唑仑是正在尝试使用的新型药物,有望提升TIVA的实践水平。在持续研究安全有效的药物的同时,TIVA也在与多种药物和辅助药物联合使用,以克服每种药物的缺点,并提供全面、平衡的麻醉效果,同时在术后恢复和疼痛缓解方面带来额外益处。针对特殊人群的TIVA调整仍在进行中。数字技术与移动应用程序的进步扩大了TIVA在日常使用中的范围。指南的制定和更新可以建立安全有效的TIVA实践。

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验